@MJNokin
Our latest publication online now! rdcu.be/dSvhN @NatureCommsView quoted post on X
Amazing team work @lab_santamaria @MJNokin @BiagioRicciutMD @DrMarkAwad @NadalErnest @cereda_lab
www.cell.com In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant... Nokin et al. identify two redox-related cellular states that involve an adaptive drug-tolerant stage followed by a genetic-defined resistance phase in BRAFV600E-driven lung cancer. Timely treatments... Congratulations to Rebekah Crake, postdoc in our team, who received a @GSK award for her great talk on targeted therapy resistance in BRAF NSCLC at the BeRS meeting today in Brussels! @belgian_society @DidierCataldo @UniversiteLiege @GIGA_ULiegeView quoted post on X
And as a "cherry on the cake", very humble to receive this award. Great to see that tRNAs are attracting interest! @pierreclose1 @GIGA_ULiege @frsFNRS . Many thanks @ISCaM_Society !View quoted post on X
